Overview

Light is all around us, but did you know its properties could be harnessed to promote brain health?

Photobiomodulation (PBM), also known as low-level light therapy, is a non-invasive technology that uses low-intensity light to stimulate cellular processes in living tissues. When applied to the brain, in a method known as transcranial photobiomodulation (tPBM), it has shown promise in enhancing cognitive function, reducing the symptoms of neurological disorders, and promoting overall brain health.

This emerging field of research suggests that the controlled exposure of the brain to specific wavelengths of light may have therapeutic benefits and potential implications for conditions that have been difficult to treat, like Alzheimer’s and Parkinson’s, depression, anxiety, and traumatic brain injuries.

Join us for this exciting webinar hosted by research expert, Maria Da Costa from Neuronic, exploring photobiomodulation. And for a deeper dive into this topic, check out our new online course on PBM for Brain Health!

Watch the Lecture

Maria Da Costa, Research Coordinator for Neuronic

Maria graduated from Nova Southeastern University with a bachelor’s in Biology and a minor in Psychology. During her time as a Student Researcher at NSU Rumbaugh-Goodwin Institute for Cancer Research, she conducted controlled experiments using various laboratory techniques, such as gel electrophoresis, Western Blot, and qPCR. Maria contributed to research projects, including studying cell cycle arrest induced by histone acetylation and exploring epigenetic modifications in genes associated with tumorigenesis. Upon graduation from NSU, Maria worked in the Department of Immunology and Microbiology at the University of Miami. There, she specialized in cultivating primary intestinal mice organoids, maintained precise records, and conducted experiments related to immunotherapy treatments. She also managed transgenic mouse databases and summarized experimental data. At Neuronic, Maria’s role as Research Coordinator consists of managing a wide spectrum of research projects involving the Neuradiant 1070 PBM device. This includes overseeing collaborations with clinics and researchers interested in further expanding the PBM research field and orchestrating large-scale clinical trials, both within and outside Neuronic. She leads the design and execution of Neuronic’s first clinical trial, dedicated to assessing the impact of the Neuradiant device on individuals with Mild Cognitive Impairment (MCI). Maria also handles vital communications with regulatory entities such as the FDA to secure a path towards obtaining medical device licenses.


The future of brain health.

Neuronic was founded with a singular focus: to keep the brain capacity in all stages of life high. Our mission is to empower lives through light therapy and neuroscience. We develop cutting-edge devices, such as the Neuradiant 1070 helmet, and invest 100% profits into product development and clinical research in the effort to obtain medical approval.